In this specific disease, insulin-like growth factor 1 (IGF-1) polymorphisms seem to have a higher influence on bone loss than the collagen type Iα1 Sp1 polymorphism, which was previously evaluated in primary osteoporosis [46, 47]. Here, IGF1 is linked to osteoporosis.